January 2012 Florida Pharmacy Journal

20
JAN. 2012 The Official Publication Of The Florida Pharmacy Association Enhancing Your CQI Program with Effective Peer Review Practices

description

January 2012 Florida Pharmacy Journal

Transcript of January 2012 Florida Pharmacy Journal

Page 1: January 2012 Florida Pharmacy Journal

JAN. 2012

The Official PublicationOf The Florida Pharmacy Association

Enhancing Your CQI Program with Effective Peer Review Practices

Page 2: January 2012 Florida Pharmacy Journal
Page 3: January 2012 Florida Pharmacy Journal

J A N U A R Y 2 0 1 2 | 3

VOL. 75 | NO. 1JANUARY 2012 the OfficiAL pUbLicAtiON Of thefLORidA phARmAcY AssOciAtiONP H A R M A C Y T O D A Y

florida

Departments 4 calendar

4 Advertisers

5 president’s Viewpoint

7 executive insight

15 foundation News

19 buyer’s Guide

Featuresenhancing Your continuous Quality improvement program with effective peer Review practices

fpA NeWs

10

12

Page 4: January 2012 Florida Pharmacy Journal

4 | f L O R i d A p h A R m A c Y t O d A Y

E-mAil your suggEstioNs/idEAs to

[email protected]

Mission Statements:of the florida pharmacy today JournalThe Florida Pharmacy Today Journal is a peer reviewed journal which serves as a medium through which the Florida Phar-macy Association can communicate with the profession on advances in the sciences of pharmacy, socio-economic issues bearing on pharmacy and newsworthy items of interest to the profession. As a self-supported journal, it solicits and accepts advertising congruent with its expressed mission.

of the florida pharmacy today board of directors The mission of the Florida Pharmacy Today Board of Directors is to serve in an advisory capacity to the managing editor and execu-tive editor of the Florida Pharmacy Today Journal in the establishment and interpreta-tion of the Journal’s policies and the manage-ment of the Journal’s fiscal responsibilities. The Board of Directors also serves to motivate the Florida Pharmacy Association members to secure appropriate advertising to assist the Journal in its goal of self-support.

AdvertisersABBOT ............................................................... 20EPC ..................................................................... 13HEAlTHCArE COnsulTAnTs ....................... 3KAHAn ◆ sHIr, P.l. .......................................... 6PPsC ..................................................................... 6rx OWnErsHIP ................................................ 19rx rElIEf ......................................................... 13unIvErsITy Of flOrIdA ............................ 13WAlgrEEns ...................................................... 2

2012

FPA Calendar JANuAry

2 FPA Office Closed for New Year’s Day

5 FPA GAC Conference Call

10 Legislative Session Begins

16 FPA Office Closed for Martin Luther King’s Birthday

20 Journal Board Conference Call

24-25 Pharmacy Days at the Florida Capitol

25 Florida Pharmacy Health Fair at the Florida Capitol

28 - 29 FPA Law and Consultant ConferenceSandestin

31 Deadline for the submission of FPA Election Ballots

FEbruAry

7-8 Florida Board of Pharmacy MeetingSt. Augustine

29 Awards nomination due

mArch

9-12 APhA MeetingNew Orleans, Louisiana

24-25 FPA Council, Committee and Board meetings

April

6 Good Friday, FPA Office Closed

10-11 Florida Board of Pharmacy Meeting Jacksonville

21-22 FPA Clinical Consultant ConferenceTampa

29-30, May 1 - NASPA Leadership Retreat

mAy

19 FPA Law and Regulatory Meeting

21-23 ASCP Spring MeetingAnaheim, California

28 Memorial Day - FPA office closed

cE crEdits (CE cycle)The Florida Board of Pharmacy requires 10 hours LIVE Continuing Education as part

of the required 30 hours general education needed every license renewal period.Pharmacists should have satisfied all continuing education requirements for this

biennial period by September 30, 2011 or prior to licensure renewal.*For Pharmacy Technician Certification Board Application, Exam Information and

Study materials, please contact the FPA office.For More Information on CE Programs or Events:Contact the Florida Pharmacy Association at (850) 222-2400 or visit our Web site at

www.pharmview.com

coNtActsFPA — Michael Jackson (850) 222-2400FSHP — Michael McQuone (850) 906-9333U/F — Dan Robinson (352) 273-6240FAMU — Leola Cleveland (850) 599-3301NSU — Carsten Evans (954) 262-1300

disclAimEr Articles in this publication are designed to provide accurate and authoritative information with respect to the subject matter covered. This information is provided with the under-standing that neither Florida Pharmacy Today nor the Florida Pharmacy Association are engaged in rendering legal or other professional services through this publication. If expert assistance or legal advice is required, the services of a competent professional should be sought. The use of all medications or other pharmaceutical products should be used according to the recommendations of the manufacturers. Information provided by the maker of the product should always be consulted before use.

For a complete calendar of events go to www.pharmview.com

Page 5: January 2012 Florida Pharmacy Journal

J A N U A R Y 2 0 1 2 | 5

E-mAil your suggEstioNs/idEAs to

[email protected]

The members of the Organiza-tional Affairs Council have been hard at work. We are a small but

mighty group of FPA member phar-macists and student pharmacists from across the state that has been charged to consider matters and issues pertain-ing to the structure, function and de-velopment of the association. President Bob Parrado has asked this council to focus on membership and how we can serve YOU, OUR MEMBERSHIP, bet-ter. According to Mr. Merriam and Mr. Webster, membership is “the state or status of being a member.” Well…not to disagree, but I think membership is a lot more. Signing up and paying dues is one thing, but being involved in your profession is what FPA membership is all about. We are the premier organiza-tion that represents YOU, the pharma-cy stakeholders in Florida in YOUR en-deavors to provide quality healthcare to YOUR patients. Here are some high-lights on how the Organizational Af-fairs Council has been able to accom-plish this thus far.

Our first task was to create member-ship materials that highlight the pow-er statement FP3A – Fostering Pharma-cist Patient & Political Advocacy and our President’s theme of “Catching the Ad-vocacy Fever.” Not only has the phar-macist brochure been updated and continually distributed, but the Board of Directors has recently approved the new pharmacy technician brochure that should be hitting the presses short-ly. Keep your eyes peeled! In these bro-chures we showcase all of the wonder-ful benefits FPA membership provides, including the always important rep-resentation to the Legislature. As the Professional Affairs Committee stat-

ed in its report, membership “is one of the most critical ways that the Florida Pharmacy Association can communi-cate to legislators what it is that phar-macists can do for the patients of our state.” Being an active member pro-vides you with that representation.

In addition, the Organizational Af-fairs Council wants to make sure that FPA is representing YOU to the best of our abilities. Therefore, we have creat-ed membership needs assessment sur-veys for both pharmacists and phar-macy technicians to understand not only the areas that FPA is doing well but also the areas that we can im-prove in. The survey links were pub-lished in the December 9, 2011, is-sue of STAT News. You can view that edition by logging into the website (www.pharmview.com) with your user ID and password. Please take a mo-ment (it is short I promise) to complete this survey and give us your honest opinion. Each of your responses will be discussed and will be considered in making recommendations to the Board of Directors. Only if you speak up can YOUR VOICE be heard and we can represent YOU better. Again…please complete the survey.

Working along with the Profession-al Affairs Council’s “4 graph” project, the Board of Directors has approved a membership PowerPoint presentation that directly communicates to mem-bers and non-members alike about the true value of FPA membership. It cov-ers not only the direct tangible benefits, including discounted CE registration costs, but also the non-direct intangible benefits such as representation before the Florida Legislature, Board of Phar-macy or other state and federal agen-

cies. This PowerPoint presentation will be given to the Unit Associations to use during their regular meetings to help retain current members and to gain new ones. Be on the lookout for that presentation!

Finally, the Organizational Affairs Council is looking forward to review-ing all of the Unit Association Awards applications in the near future. Each of you work hard for the profession of pharmacy, and we would like to re-ward you for your effort.

If anyone would like to join the Council for the next year, we are al-ways looking for new and fresh ideas. President-elect Goar Alvarez will be putting together his leadership team, and would like to hear from you. Goar can be reached at [email protected]. n

Sincerely, Lisa R. ClayvilleChair

Membership is KEY for the Organizational Affairs Council this Year

The President’s Viewpointby guEst columNist lisA clAyVillE,

orgANiZAtioNAl AFFAirs couNcil chAir

lisA clAyVillE organizational Affairs council chair

Page 6: January 2012 Florida Pharmacy Journal

6 | f L O R i d A p h A R m A c Y t O d A Y

I n d e p e n d e n t … B u t N o t A l o n e .P P S C i s Y o u r P a r t n e r f o r S u c c e s s

IncreaseProfits

Every day, pharmacies depend on PPSC to simplify purchasing, reduce costs and identify new revenue sources – making a significant impact on their bottom line.

PPSC can help you:EXPAND use of high-profit genericsCREATE effective store layoutENHANCE third-party profitsCAPTuRE MTM revenue EsTAblisH new business nichesINCREASE your overall margins

For more on how PPSC can maximize the potential of your independent pharmacy, visit www.ppsconline.com or call toll-free 888-778-9909.

JOIN TODAY!

Florida Pharmacy Association

A PhArmAcist And A LAwyer

Board of Pharmacy Licensure Disciplinary ProceedingsChapter 499 Violations, Pharmacy Audit Disputes

Mergers and AcquisitionsCommercial, Civil and Criminal Proceedings

KAHAN ◆ SHIR, P.L.

Pharmacist AttorneyBrian A. Kahan, R.Ph., J.D.

Licensed Florida Pharmacist and Attorney

STATEWIDE REPRESENTATION

[email protected]

1800 N.W. Corporate Blvd., Suite 200 Boca Raton, FL 33431

The hiring of a lawyer is an important decision that should not be based solely upon advertisements. Before you decide, ask us to send you free written information about our qualifications and experience.

Page 7: January 2012 Florida Pharmacy Journal

J A N U A R Y 2 0 1 2 | 7

It seems like only a few years ago that the Florida Pharmacy Associa-tion celebrated its centennial at the

Sheraton St. Johns hotel in Jacksonville. It is hard to believe that it was actual-ly in 1987.

Many of you may not be aware of this, but the FPA began in that North-east Florida seaport town at a meeting at the Board of Trades room at the cor-ner of Main and Adams streets. Isn’t it ironic that the current home of the Flor-ida Pharmacy Association is on an Ad-ams Street in Tallahassee? Well, this original organizational meeting took place on May 12, 1887. It is interesting that this was the same year that the Constitution for the State of Florida, which was drawn up by the Constitu-tional Convention in 1885, was adopt-ed. It is also the year for the founding of the City of Rockledge and the be-ginnings of Florida A&M University. We also saw the creation of Citrus and Pasco counties.

The first president of the “Florida Pharmaceutical Association” was Dr. Henry “Hy” Robinson, who graduat-ed from the University of Pennsylva-nia School of Medicine. He was born in South Carolina and served as an assis-tant surgeon with the rank of Captain in the Army of the Confederacy in Mar-ianna. Eventually, he became mayor of Jacksonville.

Why am I sharing all this with you? Well, for one thing you may not real-ize that the FPA is approaching anoth-er milestone. This year we will be ap-proaching our 125th year of service to the profession, practice and business of pharmacy. We want to take this brief moment to thank our many members who have faithfully been card-carrying FPA advocates throughout their profes-sional careers.

Members such as Raymond Johns of Winter Haven and George Bokas of

Gulf Breeze have held continuous ac-tive membership in the Florida Pharma-cy Association since 1950 and 1951 re-spectively. These two gentlemen, along with many others, are true champions of your profession. We are truly hon-ored that they are so committed to the mission and vision of the FPA that they have sustained their relationship with the FPA over the years. I am sure they have seen a lot of change in the way pharmacy is practiced.

Speaking of change, members need to be aware that as you read this mes-sage from me, the legislative session has begun. We published in the December issue of Florida Pharmacy Today some of the bills that will be considered by the Florida House and Senate. We have also published on a special section of the FPA website the bills with targeted links that will provide you the most up-to-date information on that bill’s status.

Remember that the Florida Legisla-ture will review from 3,000 to 5,000 in-dividual legislative proposals. Fewer than 10 percent ever get signed into law by the governor. Some that do get to the governor’s desk could have a signif-icant impact on your practice and your business. The FPA has a Governmen-tal Affairs Committee that will be meet-ing weekly by conference call to review these bills and advise the FPA on action to take. Each of you also has a region-al director that sits on the FPA Board of Directors that will be monitoring this process as well.

If you want to monitor the progress of pharmacy-related health care bills go to our website at www.pharmview.com and slide your cursor over the “Advoca-cy” menu item. If you see a drop-down menu item labeled as “FPA Legislative Hotline – TAKE ACTION,” select that option. That will take you to your legis-lative action center where the bills that we are either monitoring or actively en-

gaged in are listed. They can be located under the “Issues” link. Special target-ed links have been created within each bill listing that will direct you to the site that has up-to-the-minute status of each bill. This may help you get answers to what is happening to each proposal in case FPA staff can’t respond to your calls on what is happening to various bills.

You may recall House bill 7095 from the 2011 legislative session. This bill, which was first reported by the FPA, had far reaching implications on the profession and business of pharmacy. We are thankful for the many members that stepped in to share their concerns with members of the Florida House and Senate. Keep connected with the FPA so that discoveries like this can be shared with you. Our profession has been actively engaged in the policy-making process for 125 years. The need to continue our monitoring has not di-minished and will be necessary for the next 125 years. n

Executive Insightby michAEl JAcksoN, rph

FPA Approaching a Milestoneby michAEl JAcksoN, FpA ExEcutiVE VicE prEsidENt/cEo

michael Jackson, b.pharm

Page 8: January 2012 Florida Pharmacy Journal

8 | f L O R i d A p h A R m A c Y t O d A Y

Executive Vice President/CEOMichael Jackson

(850) 222-2400, ext. 200Director of Continuing Education

Tian Merren-Owens, ext. 120Controller

Wanda Hall , ext. 211 Educational Services Office Assistant

Stacey Brooks , ext. 210

FloridA phArmAcy todAy boArdChair............................................. Jennifer Pytlarz, BrandonVice Chair ..................Don Bergemann, Tarpon SpringsTreasurer ..............................Stephen Grabowski, TampaSecretary ........................Stuart Ulrich, Boynton BeachMember .................................... Joseph Koptowsky, MiamiMember .............................Rebecca Poston, TallahasseeExecutive Editor ........Michael Jackson, TallahasseeManaging Editor ........................Dave Fiore, Tallahassee

This is a peer reviewed publication. ©2011, FLORIDA PHARMACY JOURNAL, INC.

ARTICLE ACCEPTANCE: The Florida Phar-macy Today is a publication that welcomes articles that have a direct pertinence to the current practice of pharmacy. All articles are subject to review by the Publication Review Committee, editors and other outside referees. Submitted articles are received with the understanding that they are not being considered by another publication. All articles become the property of the Florida Pharmacy Today and may not be published without written permission from both the author and the Florida Pharmacy Today. The Florida Pharmacy Association assumes no responsibility for the statements and opinions made by the authors to the Florida Pharmacy Today.

The Journal of the Florida Pharmacy Association does not accept for publication articles or letters concerning religion, politics or any other subject the editors/publishers deem unsuitable for the readership of this journal. In addition, The Journal does not accept advertising material from persons who are running for office in the association. The editors reserve the right to edit all materials submitted for publication. Letters and materials submitted for consideration for publication may be subject to review by the Editorial Review Board.

FLORIDA PHARMACY TODAY, Annual sub-scription - United States and foreign, Indi-vidual $36; Institution $70/year; $5.00 single copies. Florida residents add 7% sales tax.

Florida Pharmacy association

610 N. Adams St. • Tallahassee, FL 32301850/222-2400 • FAX 850/561-6758

Web Address: http://www.pharmview.com

FPA STAFFThe Florida Pharmacy Association gratefully acknowledges the hard work and dedication of the following members of the FPA leadership who work deligently all year long on behalf of our members.

Humberto Martinez ............................................................ Chairman of the BoardRobert Parrado .........................................................................................FPA PresidentGoar Alvarez .............................................................................................. President ElectBetty Harris ............................................................................................................TreasurerSuzanne Wise ...........................................Speaker of the House of DelegatesEric Alvarez ....................................Vice Speaker of the House of DelegatesPreston McDonald, Director ...........................................................................Region 1Marcus Dodd-o, Director .................................................................................Region 2Eva Sunell, Director .............................................................................................Region 3 Raul N. Correa, Director ...................................................................................Region 4 Jeffrey Parrado, Director ..............................................................................Region 5 Chris Lent, Director ..............................................................................................Region 6Paul Rohrbaugh, Director ................................................................................. Region 7Raul Gallo, Director ................................................................................................Region 8Paul Elias, Director ................................................................................................Region 9Venessa Price ......................................................................................... President FSHPMichael Jackson .......................................Executive Vice President and CEO

Florida pharmacy today Journal board

Chair......................................................Jennifer Pytlarz, [email protected] Chair ........................................................ Don Bergemann, [email protected] ...................Stephen Grabowski, [email protected] ..................................................................Stuart Ulrich, [email protected] ................................................Joseph Koptowsky, [email protected] .......................Rebecca Poston, [email protected] Editor ...............Michael Jackson, [email protected] Editor ..................Dave Fiore, [email protected]

2011/2012 FpA board of directors

Page 9: January 2012 Florida Pharmacy Journal

J A N U A R Y 2 0 1 2 | 9

HELP SUPPORT THE ADOPT-A-STUDENT PROGRAM Florida Pharmacy Association

122nd Annual Meeting & Convention July 4-8, 2012

The Marco Island Marriott Resort, Golf Club & Spa – Marco Island, Florida

Again this year, students from Florida Colleges of Pharmacy will be “Adopted” for the FPA Annual Meeting and Convention. Pharmacy students will benefit from the interaction with practicing pharmacists, learn first hand how FPA actually operates and how they can become involved in their chosen profession. As you remember, college students are on a tight budget and most of them cannot afford to attend convention. Here is how you can help! The cost to register/sponsor one student is $110.00. They also have travel, room and food expenses. Adopted students will receive complimentary registration, hotel accommodations and be able to attend special programs designed for them. If enough money is raised, FPA will also be able to include additional support for meals. Make a contribution yourself! Ask your local unit association or get together with friends to Adopt-A-Student. Remember…..these are the future leaders of pharmacy! Mentor Program. Each of the adopted students will be assigned a pharmacist who will invite them to attend meetings, CE programs, and share their knowledge and pharmacy experience with them. If you plan to attend the convention and would like to be a mentor, please contact the FPA office. Please fill out the form below and fax or mail with your check to:

Florida Pharmacy Association 610 North Adams Street Tallahassee, FL 32301

Fax: (850)561-6758 Please make your check payable to the Florida Pharmacy Foundation

Sponsor Name:_________________________________________________________________________ Address: ______________________________________________________________________________ City: _______________________________________ State: __________ Zip:_______________________ Phone: ________________________________ Amount of Contribution:___________________________ Charge to the following (please circle): VISA MASTERCARD DISCOVER AMEX Account #:_____________________________________Security Code:________ Exp. Date: ____________ Signature: ________________________________________________________________________________ Yes, I would like to serve as a Mentor. Contact me with more information on Mentoring. Contributions to the Florida Pharmacy Association Foundation are tax deductible as a charitable contribution for federal income tax purposes. Consult your CPA for complete details.

Page 10: January 2012 Florida Pharmacy Journal

10 | f L O R i d A p h A R m A c Y t O d A Y

The fundamental feature of a Continuous Quality Im-provement (CQI) program that distinguishes it from a simple medication error reporting system is the pursuit of WHY the quality-related event (QRE) occurred.

This article examines how to start a Peer Review program to answer the WHY questions in a way that avoids creating a punitive and blaming culture. Equally important, peer re-view methods can help identify effective systems-based cor-rective actions. All pharmacy employees should become fa-miliar with the peer review steps that take place after a QRE report is submitted. This familiarity reduces anxiety and pro-motes cooperation toward a positive outcome.

identifying the causes of Quality-related Events (QrEs)

While the initial reports describe WHAT went wrong, the role of Peer Review is to identify WHY things went wrong. For example, a dispensing error occurs while the pharmacist was called to the phone during the final check. Peer review identifies that there are no safeguards to protect the pharma-cist from interruptions during the final check and no system to restart the final check after the interruption. The causes behind this error might therefore be rooted in faulty proce-dures and human factors (e.g. distractions) and not based on the competence or dedication of the pharmacist. Unless cor-rected, these underlying failures increase the risk for future errors, regardless of who is dispensing or checking the pre-scription.

If the “first story” about a QRE tells WHAT happened, the “second stories” are the stories that the pharmacist and tech-nicians often talk about afterwards. Common second stories often describe normal practices such as:

n “We always take telephone prescriptions from Dr. Smith’s office clerk.”

n “That customer always refuses my offer to counsel so I’ve stopped offering.”

n “Pharmacist Jones always fills problem prescriptions but he places a note on the bag to check with him before dis-pensing.”

n “The computer sends too many alerts so we always an-swer yes to the override.”

Often, QREs occur in seemingly “normal” situations. It is only after more careful peer review that these “normal” situ-ations are in fact, seen as not normal.

beginning the peer review and investigating the QrE

Fundamentally, there are two types of retrospective anal-ysis differing primarily in their intensity, time and cost: 1) in-tensive investigation; and 2) root cause analysis (RCA). Each analysis is described in more detail in the text box. Impor-tantly, each type of analysis is conducted under the peer re-view protections of a Patient Safety Organization (PSO).

Intensive investigations do not accept the apparent or “first story” causes of error (e.g. “it was busy when I did the final check”). They seek out and probe for WHY the error occurred in that particular instance compared to any other time. They ask what part of the system failed and WHY it failed. Peer re-view also assures that others agree with the suspected reason for the system failure and the suggested improvement plans are acceptable to other practitioners. Peer review helps min-imize bias in analyzing the cause of error and helps assure that the improvement plan is likely to be effective.

Enhancing Your Continuous Quality Improvement Program with Effective Peer Review Practices

intensive investigationIntensive investigation involves a series of questions

that attempt to identify the systems failures and human factors that contributed to a QRE. Intensive investiga-tions are thorough and do not accept the apparent cause of the error.

n Factual, evidence-based, systems-focused, nonpuni-tive

n Timely, quick (15 -30 min) and low cost

root cause Analysis (rcA) Root cause analysis (RCA) is a formal, rigorous, struc-

tured diagnosis of a serious error or potential error that is likely to be repeated unless the underlying failures are corrected.

n Factual, evidence-based, systems-focused, non-puni-tive

n Extremely comprehensive, may involve outside ex-perts, time intensive, more expensiveRCA is the type of detailed and lengthy analysis con-

ducted by the National Transportation Safety Board fol-lowing aircraft accidents. This type of analysis is re-served for use after rare serious events. The RCA should be conducted by persons with experience in risk manage-ment and medication safety.

Page 11: January 2012 Florida Pharmacy Journal

J A N U A R Y 2 0 1 2 | 11

This is the recommended method of analysis that will be most useful for routine use in community pharmacy CQI programs. Intensive investigations gather “first hand” evi-dence of what happened, with concise, clear and detailed de-scriptions of the persons involved, timing of the event, the environment, the policies and procedures involved and the “second stories” that staff tell about this event and similar events in the past. It includes collecting physical evidence such as copies of the original prescription, telephone notes, labels, computer display and other facts.

peer review identifies the human performance Factors that contribute to QrE

After a QRE, it is too easy to be critical of human perfor-mance; somewhat like the tendency to be a Monday-morn-ing quarterback. Peer review takes a more measured ap-proach and puts the reviewer “in the shoes” of the persons involved in the QRE, under the same conditions at the time of the event.

Overall, human performance in a poorly designed system will result in more error. While systems-based errors are the major cause of QREs, a complete peer review will always look at the way practitioners work within the system. If the QRE is due to mental slips and lapses, the performance fail-ures may be due to fatigue, distraction and information over-load. The underlying system failure may ultimately be work-load management, workflow management or poorly defined job responsibilities. If the QRE is due to a judgment error, the performance failure may be due to high stress or making wrong assumptions. The underlying system failure may ul-timately be an over-reliance on memory for critical steps, lack of readily available drug and patient information, or work en-vironments that create unnecessary and dysfunctional stress. At times, non-work related family and life stresses add to the complex mix of factors that lead to QREs.

peer peview and corrective ActionsThe end-game of peer review is to identify corrective ac-

tions that improve systems and decrease the risk of human performance failures. Peer review helps assure that the pro-posed corrective actions will be effective and accepted by others. While one person might propose “the fix”, collective input from other employees will help assure that the “fix” is a workable solution. For example, it is unlikely that brief edu-cation and training or admonishing people to “be more care-ful” will prevent human performance errors. To effectively reduce errors, the workflow system itself needs to be rede-signed with the limitation of human performance in mind.

The PQC™ participant is assigned a unique, encrypted password and username that allows entry to the APMS PQC Resource Area. The Daily Process Related Event Reporting form and the PQC™ Quality Management Tools Process Improvement Form (to assist in determining Root Cause Analysis) can be found there.

tips oN stArtiNg A pEEr rEViEW procEss

The pharmacy’s policy and procedure should de-scribe how the Peer Review process works, even in a small pharmacy with very few employees. The peer review work may be delegated to a pharmacist or ex-perienced technician who has a special interest in safety and quality. The pharmacist-manager is ulti-mately responsible for the CQI program and for ap-proving any corrective actions.

1. Gather and preserve the physical evidence and stories of those involved in the QRE.

2. Describe the QRE in terms of WHAT happened (not what was supposed to happen).

3. Make notes only on documents that are protected by the PSO.

4. Conduct private personal interviews that use a se-ries of WHY questions to describe the QRE, the environment at that time and the characteristics of similar QREs. The WHY question might need to be asked several times to truly understand what happened. Each “human error” must have a preceding cause. The interview should result in a clearer picture of WHY the procedures or prac-tice led to the QRE.

5. Identify possible failures in the systems (e.g. pro-cedures, policies, equipment, workflow).

6. Identify possible contributing factors (e.g. envi-ronment and human performance factors).

7. Classify and record by type of QRE and the part of the workflow process when the QRE occurred.

8. Classify and record the causal factors and system failures.

9. Identify improvement plans. What would prevent this error in the future? What will be monitored to assure that the corrective action is working?

10. Tell each employee about the final corrective ac-tion plan and how the changes affect their job.

Page 12: January 2012 Florida Pharmacy Journal

12 | f L O R i d A p h A R m A c Y t O d A Y

d.0 and hipAA 5010 compliance is on the horizon

This is one of the more complicated issues to share with the FPA membership. On the scope of understand-ing, this one raises to level 10 on a scale of 1 to 5. Essen-tially, there is a mandate that the adoption of claims pro-cessing standards be consistent across all covered entities including pharmacy providers. This is likely driven by the significant increase in ICD10 provider service codes that have been created over the years. That standard is la-beled HIPAA 5010 and D.0. These new standards are es-sential for establishing consistency and uniformity with-in the provider and payer industries especially for claims to Medicare.

What does this mean for you, the pharmacy provider? Pharmacy claims must now be transmitted using compli-ant HIPAA 5010 and D.0 standards. Your software ven-dor and upstream claims processing vendors should be testing for compatibility. Hopefully by now your pharma-cy systems have passed these tests. The FPA has learned that the Center for Medicare and Medicaid Services an-nounced in November that enforcement of the D.0 stan-dards will not begin until March of 2012. For more in-formation, please visit the Center for Medicare and Medicaid Services web site at http://www.cms.gov/Ver-sions5010andD0/.

senate Judiciary committee hears testimony on pbm merger

On December 6, 2011, there was a hearing in Wash-ington, D.C., before the Senate Judiciary Committee on the proposed merger of Medco and Express Scripts. Ap-pearing before the committee was community pharma-cy owner Sue Sutter of Wisconsin who testified for the National Community Pharmacists Association. Concerns raised in testimony included possible challenges to the pharmacy provider market space.

reminder of New pharmacy permit requirements pending

In order to dispense controlled substances listed in Schedule II or Schedule Ill on or after July 1, 2012, a com-munity pharmacy permittee must be permitted pursuant to new requirements set forth in the law. The changes in permitting requirements that must be met for a pharma-cy to dispense Schedule II or Schedule Ill prescriptions after July 1, 2012, included, but are not limited to, fin-gerprinting requirements and written policies and pro-cedures for preventing controlled substance dispensing

based upon fraudulent representations or invalid practi-tioner-patient relationships (see first section above). The law sets forth certain convictions and termination from Medicaid as reasons for which application for a permit must be denied.

The FPA met briefly with Department of Health (DOH) staff to get information on the new permitting process. The DOH information technology team is working on an on-line application solution and it is anticipated to be available on or about January 10, 2012. The on-line appli-cation should have a way to add in the prescription de-partment manager or consultant of record. Board staff has suggested that using the on-line tools will be much faster that submitting a paper application. An application for this new pharmacy permit must include a set of fin-gerprints from each person having an ownership interest of 5 percent or greater and from any person who, directly or indirectly, manages, oversees, or controls the operation of the applicant, including officers and members of the board of directors of an applicant that is a corporation. These individuals are referred to as “affiliated persons.”

Corporations that have more than $100 million in busi-ness taxable assets will only require the prescription de-partment manager (PDM) or the consultant of record to submit a set of fingerprints. Board staff is recommend-ing that applicants use their recommended fingerprinting service provider. When the online application solution is ready there may be a field that asks for the Board’s unique number. We have been told that number is F924190Z. We believe that your existing permit will be amended with a marker indicating that you are authorized to dispense C-II’s and C-III’s after July 1 of next year.

Part of the new permit process may include a require-ment for you to submit certified copies of your corporate documents. We are hoping that the Department will ac-cept printed copies of your corporate paperwork that is available on the Florida Division of Corporations website (www.sunbiz.org).

Remember that if your pharmacy does not dispense schedule II or schedule III controlled substances you may not need to apply for this new permit, however, your ex-isting permit will expire in February of 2013 which will set you up for the new permit standards anyway. The Board at its October meeting elected to forgo assessing any new fees for this permit. There may be costs associat-ed with fingerprinting and background checks.

FPA NEWS

Page 13: January 2012 Florida Pharmacy Journal

J A N U A R Y 2 0 1 2 | 13

CONTROL YOUR ASSIGNMENTS,CONTROL YOUR CAREER

The Alternative To A Traditional Career In Pharmacy

Career n.an occupation undertaken for a significant period of a person’s life, usually with opportunities for progress.

• Guaranteed Hours • Professional Pay & Benefits• Special Clients, Flexible Assignments• A Variety Of Bonus Programs• Professional Development Opportunities/Cross Training

Professional Well-Managed Fair

04480 Hensley/RX ReliefFlorida Pharmacy Today—1/4 pg ad (3.5”x4.75”)

PHARMACY CONSULTING AND STAFFING SOLUTIONS

Empire Pharmacy Consultants305-374-1029 office305-357-6983 [email protected]

www.epcepc.com

• Part-time, Full-time, Temporary and Vacation Coverage

• Pharmacy Management Programs

• Open a Pharmacy

• EPC is Pharmacist Owned and Operated

• NO ONE CAN PROVIDE BETTER SERVICE

Online Master of Science inPharmaceutical Outcomes & Policy

http://pharmreg.dce.ufl.edu

Part Time • 30 Credits • Non Thesis Specialty Tracks:• AppliedPharmacoeconomics• PharmacyRegulation&Policy• ClinicalResearchRegulation&Ethics• PatientSafety&RiskManagement• DrugRegulatoryAffairs

UF MS / Stetson University MBA option

Page 14: January 2012 Florida Pharmacy Journal

14 | f L O R i d A p h A R m A c Y t O d A Y

The FPA Poster Presentations are open to PHARMACY STUDENTS ONLY. Complete and submit this COVERSHEET for each abstract submission. Submissions must be received no later than Monday, May 7, 2012. Abstracts will NOT be accepted after this date. Mail or E-mail this application along with the abstract submission to:

Tian Merren Owens, MS, PharmD, Director of Continuing Education Florida Pharmacy Association

610 N. Adams Street Tallahassee, FL 32301

[email protected] PLEASE TYPE Contact Information: Presenter's Name (MUST BE A STUDENT):________________________________________________________________

□ Entry Level Pharm.D. □ Post B.S. Pharm.D. Address: ________________________________________________________________________________________ City, State, Zip: ___________________________________________________________________________________ Telephone No: _____________________E-Mail Address: _________________________________________________ Abstract Title: ____________________________________________________________________________________

Poster Type: □Clinical Research

□Basic Science Research

□Translational Research (Basic Science and Clinical Research) Primary Author: __________________________________________________________________________________

(Students must be listed first to be considered for the Award. Presenter will be notified by mail of acceptance).

Co-Author(s): _________________________________________________________ Student □YES □NO

Awards: Posters will be eligible for 1st, 2nd, and 3rd place prizes to be presented at Convention. (Only one prize is given for each winning poster)

Free Registration: Three entry level students from each Florida College of Pharmacy will be eligible for a

complimentary Florida Pharmacy Association Convention Student registration. (Student Registration does not include CE or hotel accommodations)

I am interested in being considered for this registration: □YES □NO College: _____________________________________________________________________________

The abstract form submitted should be the equivalent of one page. The abstract should include: Title (Include authors’ names and name of College of Pharmacy), Purpose, Methods, Results, and Conclusions.

Abstracts will not be accepted if it is not in this format. Do not include figures or graphs.

Please direct all questions and concerns to: Tian Merren Owens ♦ (850) 222-2400 ext. 120 ♦ [email protected]

CALL FOR ABSTRACTS FOR POSTER PRESENTATIONS For Florida Pharmacy Students

FLORIDA PHARMACY ASSOCIATION 122nd ANNUAL MEETING AND CONVENTION

July 4-8, 2012 The Marco Island Marriott Resort, Golf Club & Spa ♦ Marco Island, Florida

Poster Session: Friday, July 6, 2012, 11:00AM-1:00PM

ABSTRACT FORMAT

DEADLINE DATE: MONDAY, MAY 7, 2012

Page 15: January 2012 Florida Pharmacy Journal

J A N U A R Y 2 0 1 2 | 15

The Board of Trustees voted to honor Foundation Board member Al Tower with an award in his name -- the Florida Phar-macy Foundation Alton Tower Philanthro-py Award. A cash award of $500 will be presented to the winner’s choice of char-ity/organization and a plaque will be pre-sented to the winner annually at the Flor-ida Pharmacy Association’s awards night, during convention.

The word “philanthropy” means to give of oneself, which describes the life of Al Tower. Al has given so much to the profession of pharmacy and has re-ceived the R.Q. Richards Award, James H. Beal Pharmacist of the Year Award, Sid-

ney Simkowitz Pharmacist Involvement Award, Jean Lamberti Mentor Award, IPA Corrons Inspiration & Motivation Award, U.B. Willis Greg-ory Award, Abilities Guild in Community Serving Award and the Bowl of Hygeia Award.

He has held leadership roles in many organizations including the Pinellas County Pharmacy Association, Florida Pharmacy Association, Christian Pharmacists Fellowship International and the American Phar-macists Association.

Al is very active in his community, serving on the boards of many healthcare organizations such as the American Cancer Society, Future Scientists of America, and Florida Tobacco-Free Coalition. He also has been a career speaker in public schools.

As the Chair of the Florida Pharmacy Foundation Fundraising Com-mittee, Al set a goal for the Trustees to raise $300,000 for scholarships. The plan was that the interest earned on the endowment would fund new scholarships for pharmacy students.

Congratulations, Al.

If you wish to make contribution to the Award in honor of Al, please make your check payable to the Florida Pharmacy Foundation Alton Tower Philanthro-py Award, 610 N Adams St. Tallahassee, FL 32301.

Florida Pharmacy FoundationAnnounces the

Alton Tower Philanthropy Award

Al toWEr

criteria forFloridA phArmAcy FouNdAtioN

AltoN toWEr philANthropy AWArd

The Florida Pharmacy Foundation is pleased to present this award in honor of Al Tower. Please follow all of the required cri-teria. The Selection Committee will review all applicants and make the final decision. Only the winner will be notified. There is a cash award of $500 presented to the winner’s choice of charity/ organization and a plaque presented to the winner at the Annual Meet-ing of the Florida Pharmacy Association Awards Night at The Marriott Resort, Marco Island on Saturday, July 7, 2012.

I nominate___________________________Philanthropist of the Year for his/her involvement in a

n charitable organization/s that meets the criteria below:

n Elaborate reason for nomination: motiva-tion, enthusiasm

n Membership/ serving as an officer, com-mittee chair

n Effort to inform community about organi-zation

n Community service project/s participation n Contributing factors of success with

project/s n Speaking engagements

Please limit your typed submission to 3 pages.Send 4 copies to: Patsey J. Powers, Executive Vice PresidentFlorida Pharmacy Foundation610 N. Adams StreetTallahassee, FL 32301

Deadline for submission is April 15, 2012

UPDATED

Page 16: January 2012 Florida Pharmacy Journal

16 | f L O R i d A p h A R m A c Y t O d A Y

c A L L f O R N O m i N A t i O N s F p A A W A r d s 2 0 1 1 - 2 0 1 2

AphA Foundation and NAspA bowl of hygeia

Awarded to a pharmacist for out-standing community service above and beyond professional duties. The use of the following selection criteria is re-quired:

n The recipient must be a Florida li-censed pharmacist and a member of FPA.

n The recipient must be living. Awards are not presented posthumously.

n The recipient has not previously re-ceived the award.

n The recipient is not currently serving nor has he/she served within the immediate past 2 years on its award committee or an officer of the asso-ciation in other than an ex officio ca-pacity.

n The recipient has compiled an out-standing record of community ser-vice, which, apart from his/her spe-cific identification as a pharmacist, reflects well on the profession.

James h. beal AwardAwarded to the "Pharmacist of the

Year." The criteria established for this award is that the recipient be a Flori-da registered pharmacist and a mem-ber of FPA, who has rendered outstand-ing service to pharmacy within the past five years.Criteria:

n The recipient must be a Florida reg-istered pharmacist and a member of the FPA.

n The recipient has rendered outstand-ing service to pharmacy within the past five years.

technician of the year AwardAwarded annually to a Florida phar-

macy technician who is recognized for his/her outstanding performance and achievement during his/her career.

Criteria: n Candidate must be a member of the

Florida Pharmacy Association for at least 2 years.

n Candidate must have demonstrated contributions and dedication to the advancement of pharmacy techni-cian practice.

n Candidate must have demonstrated contributions to the Florida Pharma-cy Association and/or other phar-macy organizations.

n Candidate must have demonstrated commitment to community service.

n Candidate is not a past recipient of this award.

r.Q. richards AwardThis award is based on outstanding

achievement in the field of pharmaceu-tical public relations in Florida.Criteria:

n The recipient must be a Florida reg-istered pharmacist and a member of the FPA.

n The recipient has displayed out-standing achievement in the field of pharmaceutical public relations in Florida.

Frank toback/AZo consultant pharmacist AwardCriteria:

n Candidate must be an FPA member, registered with the Florida Board of Pharmacy as a consultant pharma-cist in good standing.

n Candidate should be selected based on their outstanding achievements in the field of consultant pharmacy.

dcpA sidney simkowitz pharmacy involvement Award

Presented annually to a Florida pharmacist who has been active at the local and state pharmacy association level in advancement of the profession of pharmacy in Florida.Criteria:

n A minimum of five years of active involvement in and contributions to the local association and FPA.

n Candidate must have held office at local level pharmacy association.

n Member in good standing for a pe-riod of at least five years in the FPA and must have served as a member or chairman of a committee of the association.

n Candidate must have been active-ly involved in a project that has or could potentially be of benefit to members of the profession.

pharmacists mutual companies distinguished young pharmacist Award

Awarded to a young pharmacist for their involvement and dedication to the practice of pharmacy.Criteria:

n Licensed to practice for nine (9) years or less.

n Licensed to practice in the state in which selected.

n Participation in national pharmacy association, professional programs, and/or community service.

ipA roman maximo corrons inspiration & motivation AwardInteramerican Pharmacists Associa-tion created this award to honor the memory of Roman M. Corrons who in-spired and motivated countless phar-macists to participate actively and as-pire to take on leadership roles in their profession. Roman was always there with guidance and support that moti-vated pharmacists and encouraged vi-sionary leadership, approachable active membership and succession planning. This award recognizes the motivators among us who inspire others to contin-ue to advance the profession.Criteria:

n The recipient must be a Florida Li-censed Pharmacist and a member of the FPA.

n Candidate should motivate others to excel within the profession by en-couraging them to be leaders.

n Candidate is not necessarily an asso-ciation officer, but guides, supports and/or inspires others.

A brief description on the candidate’s motivational/inspirational skills must accompany the nomination.

the Jean lamberti mentorship Award

The Jean Lamberti Mentorship Award was established in 1998 to honor those pharmacists who have taken time to share their knowledge and experience with pharmacist candidates. The award is named in honor of long time FPA member Jean Lamberti for her effort in working with pharmacy students.

Page 17: January 2012 Florida Pharmacy Journal

J A N U A R Y 2 0 1 2 | 17

dEAdliNE For NomiNAtioNs: FEbruAry 28, 2012

Criteria: n The recipient must be an FPA member. n The recipient must serve as a role

model for the profession of pharmacy.

upsher smith Excellence in innovation Award

Awarded to honor practicing phar-macists who have demonstrated inno-vation in pharmacy practice that has re-sulted in improved patient care.Criteria:

n The recipient has demonstrated inno-vative pharmacy practice resulting in improved patient care.

n The recipient should be a practic-ing pharmacist within the geograph-ic area represented by the presenting Association.

Qualified Nominee: A pharmacist prac-ticing within the geographic area repre-sented by the presenting Association.

cardinal generation rx AwardThe Cardinal Health Generation Rx

Champions Award recognizes a phar-macist who has demonstrated excellence in community-based prescription drug abuse prevention. The award is intend-ed to recognize outstanding efforts with-in the pharmacy community to raise awareness of this serious public health problem. It is also intended to encour-age educational prevention efforts aimed at patients, youth and other members of the community.

The nominee must be a pharmacist who is a member of the state association. Self-nominations are allowed. Applica-tions will be evaluated based upon the following criteria:

n Commitment to community-based educational prevention efforts aimed

at prescription drug abuse n Involvement of other community

groups in the planning and imple-mentation of prevention programs

n Innovation and creativity in the cre-ation and implementation of preven-tion activities

n Scope/magnitude of prescription drug abuse effortsDemonstrated impact of prescription

drug abuse prevention efforts

I AM PLEASED TO SUBMIT THE FOLLOWING NOMINATION:

Name:

Address:

FOR THE FOLLOWING AWARD:

(Nomination Deadline February 28, 2012)

APhA Foundation and NASPA Bowl of Hygeia

James H. Beal Award

R.Q. Richards Award

Frank Toback/AZO Consultant Pharmacist Award

DCPA Sydney Simkowitz Award

Pharmacists Mutual Co. Distinguished Young Pharmacist Award

Academy of Pharmacy Practice Practitioner Merit Award

The Jean Lamberti Mentorship Award

IPA Roman Maximo Corrons Inspiration & Motivation Award

Upsher Smith Excellence in Innovation Award

Technician of the Year Award

Cardinal Generation Rx Award

NOMINATED BY:

Name:

Date Submitted:

Signature:

Please describe briefly below the nominee's accomplishments, indicating why you feel he or she should receive this award. (Attach additional sheets if necessary.)

c A L L f O R N O m i N A t i O N s F p A A W A r d s 2 0 1 1 - 2 0 1 2

F p A A W A r d s N o m i N A t i o N F o r m

mail nominatons to: annual awards, Florida Pharmacy association, 610 n. adams st., tallahassee, Fl 32301(850) 222-2400 FaX (850) 561-6758 dEadlinE For nominations is FEBrUary 28, 2012

FPA has made available an online tool to make it easier for members to nominate a colleague for an award. Visit www.pharmview.com for more information.

Page 18: January 2012 Florida Pharmacy Journal

18 | f L O R i d A p h A R m A c Y t O d A Y

phArmAcy rEsourcEs

AbbottDiabetes CareMichael J. Forker(239) 839-3313

Cerner EtrebyPharmacy Management Systems(800) 292-5590

PPSCRetail Pharmacy Purchasing Program(888) 778-9909

phArmAcy coNsultANts

HCC Pharmacy Business SolutionsDean Pedalino(800) 642-1652Mobile: (727) 460-1855

Empire Pharmacy ConsultantsMichael Chen PharmD., CPhPresident/CEO(786) 556-7825 Mobile (305) 374-1029 Office

lEgAl AssistANcE

Kahan ◆ Shir, P.L.Brian A. Kahan, R.Ph., and Attorney at Law(561) 999-5999

phArmAcEuticAl WholEsAlEr

McKesson Drug CompanyJim Springer(800) 804-4590 FAX: (863) 616-2953

tEmporAry phArmAcists –

stAFFiNg

HealthCare Consultants Pharmacy StaffingBob Miller(800) 642-1652

Empire Pharmacy ConsultantsMichael Chen PharmD., CPhPresident/CEO(305) 374-1029 Office

Rx Relief(800) RXRELIEF

bUYeR’s GUideADVERTISERS: This is a special section designed to give your company more exposure and to act as an easy reference for the pharmacist.

P H A R M A C Y T O D A Yflorida

Advertising in Florida pharmacy todaydisplay Advertising: please call (850) 264-5111 for a media kit and rate sheet. buyers’ guide: A signed insertion of at least 3X per year, 1/3 page or larger display ad, earns a placement in the Buyers’ Guide. A screened ad is furnished at additional cost to the advertiser. professional referral Ads: FPA Members: $50 per 50 words; Non-members: $100 per 50 words; No discounts for advertising agencies. All Professional Referral ads must be paid in advance, at the time of ad receipt.

AHCA MEDICAID PHARMACY SERVICES2727 Mahan DriveTallahassee, FL 32308(850) 487-4441www.fdhc.state.fl.us/medicaid/pharmacy

AMERICAN PHARMACISTSASSOCIATION (APhA)Washington, D.C. (800) 237-2742www.pharmacist.com

AMERICAN SOCIETY OF HEALTH SYSTEM PHARMACISTSBethesda, MD (301) 657-3000www.ashp.com/main.htm

DRug INFORMATION CENTERPalm Beach Atlantic University(561) [email protected]

FLORIDA BOARD OF PHARMACY4052 Bald Cypress WayBin #C04Tallahassee, FL 32399-3254(850) 245-4292www.doh.state.fl.us/mqa

FLORIDA POISON INFORMATION CENTER NETWORK(800) 222-1222www.fpicn.org

NATIONAL COMMuNITY PHARMACISTS ASSOCIATION 100 Daingerfield Road Alexandria, VA 22314703.683.8200703.683.3619 [email protected]

PHARMACY TECHNICIAN CERTIFICATION BOARD2215 Constitution Avenue NWWashington, DC 20037(800) [email protected]

RECOVERINg PHARMACISTS NETWORK OF FLORIDA(407) 257-6606 “Pharmacists Helping Pharmacists”

FrEQuENtly cAllEd NumbErs

Page 19: January 2012 Florida Pharmacy Journal

J A N U A R Y 2 0 1 2 | 19

RxOwnership.com

Buying, Selling or Starting a Pharmacy?We can help you practice pharmacy your way.Our dedicated and experienced ownership consultants can

help you achieve your goals. From planning and financing to site

selection and product mix, we deliver answers you can trust.

Set your pharmacy-ownership goals and point your future in the

right direction with the help of RxOwnership.

Visit RxOwnership.com or call 800.266.6781 today!

Page 20: January 2012 Florida Pharmacy Journal

20 | f L O R i d A p h A R m A c Y t O d A Y

Health Plan FreeStyle Lite® Precision Xtra™

Blood Glucose & Ketone Monitoring System

$600Save up to

per year*

The FreeStyle Promise® Program is a FREE benefit that provides patients with the knowledge and support they need to better manage their diabetes

Source: Formulary Compass Database™ as of Copyright ©2011 MediMedia USA, Inc. All rights reserved.

Sole Preferred – Preferred brand covered at the lowest co-pay.Preferred – Where products are physically listed on a formulary, searchable site or PDL at an approved, tier 2 or on PDL designation, including where competitors may be listed at the same level (T2/A/PDL) or higher.Covered – Status is less favorable than a competitor, unless competitors require additional restrictions such as PA, SE, etc.Prior Authorization – Covered after plan authorization; actual co-pay may vary by plan benefit.Open – Test strips are at the same reimbursement level as all other test strips offered by the plan.Customer is ultimately responsible for determining the appropriate codes and payment policies for individual patients. Abbott Diabetes Care Inc. does not guarantee third-party coverage or payment for Abbott Diabetes Care products or reimburse customers for claims that are denied by third-party payers.

FreeStyle Lite® Blood Glucose Test Strips are intended to be used with FreeStyle Lite® and FreeStyle Freedom Lite® meters only. * You are responsible for the first $15 of each co-pay under your insurance coverage. Persons on high co-pay plans may have additional responsibility, but 8 out of 10 eligible patients pay just $15 co-pay per month for test strips through the FreeStyle Promise® program. Void where prohibited. Co-pay assistance is not valid for prescriptions covered under Federal (e.g., Medicare) or similar State programs, and is not available for residents of the State of Massachusetts. Abbott can modify or rescind this offer without notice.

©2011 Abbott. ART21532 Rev. A 01/11

For In Vitro Diagnostic Use.

FreeStyle Lite® & Precision Xtra Formulary Coverage

8 out of 10 FreeStyle Promise® program

members with private insurance pay only $15 per month for program-eligible

test strips, even if their plan changes*

Aetna Preferred Preferred

TRICARE Preferred Preferred

Health First Health Plans Preferred Preferred

Preferred Care Partners, Inc. -MedicareAdvantage Plan Sole Preferred Sole Preferred

WellCare - Medicare Advantage Plan Preferred Preferred

Staywell Health Plan Preferred Preferred

Healthease Health Plan Preferred Preferred

Childrens Medical Services Preferred Preferred

Florida Medicaid Open Open

Medicare Part B Open Open

Florida

April 2011.